BackCelon Pharma S.A. Overview

Celon Pharma S.A. Receivables

Celon Pharma S.A.'s receivables is $62M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$61.66M
↑ 13.38% YoYΔ $7.28M vs prior year quarter

Peer trimmed avg / median

Loading

Celon Pharma S.A. Receivables History

Loading

Celon Pharma S.A. vs. peers: Receivables Comparison

Loading

Celon Pharma S.A. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Celon Pharma S.A. (CLN.WA) FAQ

Celon Pharma S.A. posts a receivables of $62M as of September 2026. That compares with $54M in the prior-year period — up 13.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Celon Pharma S.A.'s receivables was $54M. The latest reading is $62M — a 13.4% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Celon Pharma S.A.'s financial statement story. At $62M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CLN.WA's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Celon Pharma S.A.'s other metric pages and overview cover the third.